Literature DB >> 2790189

Autoantibodies against platelet membrane glycoproteins in children with acute and chronic immune thrombocytopenic purpura.

P Berchtold1, R McMillan, P Tani, S Sommerville-Nielsen, V S Blanchette.   

Abstract

The autoimmune nature of chronic immune thrombocytopenic purpura (ITP) in adults is widely accepted. In contrast, the pathogenetic mechanism in acute and chronic ITP in children is not known. In this report, we studied 39 children with destructive thrombocytopenia, 15 patients with acute ITP and 24 patients with chronic ITP. Platelet autoantibodies to platelet glycoprotein IIb/IIIa were detected in 14 of 24 patients (58.3%) in the chronic ITP group and in four of 15 (26.7%) with acute ITP. Binding ratios (+/- SD) of positive patients were significantly greater (P = .01) in chronic ITP (8.0 +/- 9.1) when compared with those of acute ITP where the binding ratios were only slightly above the normal range (1.9 +/- 0.4). The results show that autoantibodies against platelet glycoproteins are present in the majority of children with chronic ITP confirming the autoimmune nature of this disorder. The minimal elevation seen in the positive children with acute ITP suggests a different pathogenetic mechanism. These data suggest that this approach may be useful in differentiating acute from chronic ITP patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2790189

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Comparative study of IgG binding to megakaryocytes in immune and myelodysplastic thrombocytopenic patients.

Authors:  Doaa I Elzaeem; Esmat A El Sharkawi; Eman M Zaki; Ayman G Ghobrial; Aliaa S Abd El-Fatah; Waleed M Abd El-Hamed
Journal:  Ann Hematol       Date:  2021-05-13       Impact factor: 3.673

2.  Localization of human platelet autoantigens to the cysteine-rich region of glycoprotein IIIa.

Authors:  R Kekomaki; B Dawson; J McFarland; T J Kunicki
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

Review 3.  IVIG in the treatment of children with acute and chronic idiopathic thrombocytopenic purpura and the autoimmune cytopenias.

Authors:  D J Nugent
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

4.  Severe Thrombocytopenic Purpura Associated with COVID-19 in a Pediatric Patient.

Authors:  Adelina Raluca Marinescu; Voichita Elena Lazureanu; Virgil Filaret Musta; Narcisa Daniela Nicolescu; Alexandra Mocanu; Talida Georgiana Cut; Camelia Oana Muresan; Cristina Tudoran; Monica Licker; Ruxandra Laza
Journal:  Infect Drug Resist       Date:  2022-06-30       Impact factor: 4.177

5.  Use of Single- or Two-dose Pulse Methylprednisolone in the Treatment of Acute Immune Thrombocytopenic Purpura.

Authors:  Ayşe Bozkurt Turhan; Zeynep Canan Özdemir; Özcan Bör
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2018-03-21

6.  Anti-platelet antibodies in childhood immune thrombocytopenia: Prevalence and prognostic implications.

Authors:  David E Schmidt; Katja M J Heitink-Polle; Leendert Porcelijn; C Ellen van der Schoot; Gestur Vidarsson; Marrie C A Bruin; Masja de Haas
Journal:  J Thromb Haemost       Date:  2020-04-12       Impact factor: 5.824

7.  Expression of the 60 kDa and 71 kDa heat shock proteins and presence of antibodies against the 71 kDa heat shock protein in pediatric patients with immune thrombocytopenic purpura.

Authors:  Chengfeng Xiao; Sheng Chen; Mingchun Yuan; Fuyue Ding; Dongliang Yang; Ruibo Wang; Jianxin Li; Robert M Tanguay; Tangchun Wu
Journal:  BMC Blood Disord       Date:  2004-03-02

8.  Anti-platelet antibody immunoassays in childhood immune thrombocytopenia: a systematic review.

Authors:  David E Schmidt; Anke J Lakerveld; Katja M J Heitink-Pollé; Marrie C A Bruin; Gestur Vidarsson; Leendert Porcelijn; Masja de Haas
Journal:  Vox Sang       Date:  2020-02-20       Impact factor: 2.144

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.